| Year |
Citation |
Score |
| 2023 |
McArthur JC, Augustine EF, Carmichael ST, Ferriero DM, Jensen FE, Jeste SS, Jordan LC, Llinas RH, Schlaggar BL, Sun LR, Pomeroy SL. Recognizing and responding to the needs of future child and adult neurology care through the evolution of residency training. Annals of Neurology. PMID 37755722 DOI: 10.1002/ana.26809 |
0.462 |
|
| 2021 |
Maynard R, Poore B, Hanaford AR, Pham K, James M, Alt J, Park Y, Slusher BS, Tamayo P, Mesirov J, Archer TC, Pomeroy S, Eberhart CG, Raabe EH. TORC1/2 kinase inhibition depletes glutathione and synergizes with carboplatin to suppress the growth of MYC-driven medulloblastoma. Cancer Letters. PMID 33571541 DOI: 10.1016/j.canlet.2021.02.001 |
0.601 |
|
| 2020 |
Bhattacharya D, Pomeroy SL, Pomeranz Krummel DA, Sengupta S. Epigenetics and survivorship in pediatric brain tumor patients. Journal of Neuro-Oncology. PMID 32451770 DOI: 10.1007/S11060-020-03535-3 |
0.673 |
|
| 2019 |
Li BK, Vasiljevic A, Dufour C, Yao F, Ho BLB, Lu M, Hwang EI, Gururangan S, Hansford JR, Fouladi M, Nobusawa S, Laquerriere A, Delisle MB, Fangusaro J, Forest F, ... ... Pomeroy SL, et al. Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study. Acta Neuropathologica. PMID 31820118 DOI: 10.1007/S00401-019-02111-Y |
0.428 |
|
| 2019 |
Zhang L, He X, Liu X, Zhang F, Huang LF, Potter AS, Xu L, Zhou W, Zheng T, Luo Z, Berry KP, Pribnow A, Smith SM, Fuller C, Jones BV, ... ... Pomeroy SL, et al. Single-Cell Transcriptomics in Medulloblastoma Reveals Tumor-Initiating Progenitors and Oncogenic Cascades during Tumorigenesis and Relapse. Cancer Cell. PMID 31474569 DOI: 10.1016/J.Ccell.2019.07.009 |
0.423 |
|
| 2019 |
Hovestadt V, Smith KS, Bihannic L, Filbin MG, Shaw ML, Baumgartner A, DeWitt JC, Groves A, Mayr L, Weisman HR, Richman AR, Shore ME, Goumnerova L, Rosencrance C, Carter RA, ... ... Pomeroy SL, et al. Resolving medulloblastoma cellular architecture by single-cell genomics. Nature. PMID 31341285 DOI: 10.1038/S41586-019-1434-6 |
0.312 |
|
| 2019 |
Bihannic L, Hovestadt V, Smith K, Filbin M, Shaw M, Baumgartner A, DeWitt J, Groves A, Mayr L, Weisman H, Richman A, Shore M, Goumnerova L, Rosencrance C, Carter R, ... ... Pomeroy S, et al. PDTM-32. RESOLVING MEDULLOBLASTOMA CELLULAR ARCHITECTURE BY SINGLE-CELL GENOMICS Neuro-Oncology. 21: vi194-vi194. DOI: 10.1093/Neuonc/Noz175.808 |
0.396 |
|
| 2018 |
Archer TC, Ehrenberger T, Mundt F, Gold MP, Krug K, Mah CK, Mahoney EL, Daniel CJ, LeNail A, Ramamoorthy D, Mertins P, Mani DR, Zhang H, Gillette MA, Clauser K, ... ... Pomeroy SL, et al. Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma Subgroups. Cancer Cell. 34: 396-410.e8. PMID 30205044 DOI: 10.1016/J.Ccell.2018.08.004 |
0.67 |
|
| 2018 |
Clark AR, Calligaris D, Regan MS, Pomeranz Krummel D, Agar JN, Kallay L, MacDonald T, Schniederjan M, Santagata S, Pomeroy SL, Agar NYR, Sengupta S. Rapid discrimination of pediatric brain tumors by mass spectrometry imaging. Journal of Neuro-Oncology. PMID 30128689 DOI: 10.1007/S11060-018-2978-2 |
0.663 |
|
| 2018 |
Waszak SM, Northcott PA, Buchhalter I, Robinson GW, Sutter C, Groebner S, Grund KB, Brugières L, Jones DTW, Pajtler KW, Morrissy AS, Kool M, Sturm D, Chavez L, Ernst A, ... ... Pomeroy SL, et al. Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort. The Lancet. Oncology. PMID 29753700 DOI: 10.1016/S1470-2045(18)30242-0 |
0.576 |
|
| 2018 |
Archer TC, Sengupta S, Pomeroy SL. Brain cancer genomics and epigenomics. Handbook of Clinical Neurology. 148: 785-797. PMID 29478614 DOI: 10.1016/B978-0-444-64076-5.00050-8 |
0.76 |
|
| 2018 |
Li B, Vasiljevic A, Ho B, Norman J, Lu M, Hwang E, Hansford J, Jouvet A, Laquerriere A, Delisle M, Gururangan S, Fangusaro J, Forest F, Sumihito N, Toledano H, ... ... Pomeroy S, et al. Embr-17. Pineoblastoma Segregates Into Molecular Subtypes With Distinct Clinicopathologic Features: Report From The Rare Brain Tumor Consortium Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy059.201 |
0.37 |
|
| 2017 |
Northcott PA, Buchhalter I, Morrissy AS, Hovestadt V, Weischenfeldt J, Ehrenberger T, Gröbner S, Segura-Wang M, Zichner T, Rudneva VA, Warnatz HJ, Sidiropoulos N, Phillips AH, Schumacher S, Kleinheinz K, ... ... Pomeroy SL, et al. The whole-genome landscape of medulloblastoma subtypes. Nature. 547: 311-317. PMID 28726821 DOI: 10.1038/Nature22973 |
0.389 |
|
| 2017 |
Sengupta S, Pomeranz Krummel D, Pomeroy S. The evolution of medulloblastoma therapy to personalized medicine. F1000research. 6: 490. PMID 28713553 DOI: 10.12688/F1000Research.10859.1 |
0.653 |
|
| 2017 |
Wang B, Wu H, Chai C, Lewis J, Pichiorri F, Eisenstat DD, Pomeroy S, Leng RP. MicroRNA-1301 Suppresses Tumor Cell Migration and Invasion by Targeting the p53/UBE4B Pathway in Multiple Human Cancer Cells. Cancer Letters. PMID 28483517 DOI: 10.1016/J.Canlet.2017.04.038 |
0.728 |
|
| 2017 |
Archer TC, Mahoney EL, Pomeroy SL. Medulloblastoma: Molecular Classification-Based Personal Therapeutics. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 28386677 DOI: 10.1007/S13311-017-0526-Y |
0.602 |
|
| 2017 |
Boulay G, Awad ME, Riggi N, Archer TC, Iyer S, Boonseng WE, Rossetti NE, Naigles B, Rengarajan S, Volorio A, Kim JC, Mesirov JP, Tamayo P, Pomeroy SL, Aryee MJ, et al. OTX2 Activity at Distal Regulatory Elements Shapes the Chromatin Landscape of Group 3 Medulloblastoma. Cancer Discovery. PMID 28213356 DOI: 10.1158/2159-8290.Cd-16-0844 |
0.641 |
|
| 2017 |
Calligaris D, Clark A, Kallay L, Krummel DP, Agar J, Schniederjan M, Pomeroy S, Agar NY, Sengupta S. PATH-04. DISTINGUISHING PINEOBLASTOMA FROM MEDULLOBLASTOMAS USING TISSUE MASS SPECTROMETRY IMAGING Neuro-Oncology. 19: vi171-vi171. DOI: 10.1093/Neuonc/Nox168.695 |
0.558 |
|
| 2016 |
Wang X, Lee RS, Alver BH, Haswell JR, Wang S, Mieczkowski J, Drier Y, Gillespie SM, Archer TC, Wu JN, Tzvetkov EP, Troisi EC, Pomeroy SL, Biegel JA, Tolstorukov MY, et al. SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation. Nature Genetics. PMID 27941797 DOI: 10.1038/Ng.3746 |
0.656 |
|
| 2016 |
Jonas O, Calligaris D, Methuku KR, Poe MM, Francois JP, Tranghese F, Changelian A, Sieghart W, Ernst M, Krummel DA, Cook JM, Pomeroy SL, Cima M, Agar NY, Langer R, et al. First In Vivo Testing of Compounds Targeting Group 3 Medulloblastomas Using an Implantable Microdevice as a New Paradigm for Drug Development. Journal of Biomedical Nanotechnology. 12: 1297-302. PMID 27319222 DOI: 10.1166/Jbn.2016.2262 |
0.64 |
|
| 2016 |
Ramaswamy V, Remke M, Bouffet E, Bailey S, Clifford SC, Doz F, Kool M, Dufour C, Vassal G, Milde T, Witt O, von Hoff K, Pietsch T, Northcott PA, Gajjar A, ... ... Pomeroy SL, et al. Risk stratification of childhood medulloblastoma in the molecular era: the current consensus. Acta Neuropathologica. PMID 27040285 DOI: 10.1007/S00401-016-1569-6 |
0.349 |
|
| 2016 |
Hanaford AR, Archer TC, Price A, Kahlert UD, Maciaczyk J, Nikkhah G, Kim JW, Ehrenberger T, Clemons PA, Dančík V, Seashore-Ludlow B, Viswanathan V, Stewart ML, Rees M, Shamji AF, ... ... Pomeroy SL, et al. DiSCoVERing innovative therapies for rare tumors: combining genetically accurate disease models with in silico analysis to identify novel therapeutic targets. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27012813 DOI: 10.1158/1078-0432.Ccr-15-3011 |
0.614 |
|
| 2016 |
Hanaford AR, Archer TC, Price A, Kahlert U, Maciaczyk J, Guido N, Kim W, Ehrenberger T, Clemons P, Dancik V, Seashore-Ludlow B, Viswanathan V, Stewart M, Rees M, Shamji A, ... ... Pomeroy S, et al. Abstract 2476: DiSCoVERing innovative therapies for rare tumors: Combining genetically accurate disease models with advanced in silico analysis to identify novel therapeutic targets Cancer Research. 76: 2476-2476. DOI: 10.1158/1538-7445.Am2016-2476 |
0.362 |
|
| 2016 |
Hanaford A, Archer T, Price A, Kahlert U, Maciaczyk J, Nikkhah G, Kim JW, Ehrenberger T, Clemons PA, Dančík V, Seashore-Ludlow B, Viswanathan V, Stewart ML, Rees MG, Shamji A, ... ... Pomeroy SL, et al. MB-103DiSCoVERing INNOVATIVE THERAPIES: COMBINING GENETICALLY ACCURATE DISEASE MODELS OF MEDULLOBLASTOMA WITH ADVANCED IN SILICO ANALYSIS TO IDENTIFY NOVEL THERAPEUTIC TARGETS Neuro-Oncology. 18: iii120.3-iii120. DOI: 10.1093/Neuonc/Now076.98 |
0.583 |
|
| 2015 |
Ullrich NJ, Pomeroy SL, Kapur K, Manley PE, Goumnerova LC, Loddenkemper T. Incidence, risk factors, and longitudinal outcome of seizures in long-term survivors of pediatric brain tumors. Epilepsia. PMID 26332282 DOI: 10.1111/Epi.13112 |
0.592 |
|
| 2015 |
Archer TC, Pomeroy SL. Defining the molecular landscape of ependymomas. Cancer Cell. 27: 613-5. PMID 25965568 DOI: 10.1016/J.Ccell.2015.04.015 |
0.587 |
|
| 2015 |
Hanaford A, Archer T, Tamayo P, Pomeroy S, Eberhart C, Raabe E. MB-27 * PATHWAY ANALYSIS OF A HUMAN NEURAL STEM CELL MODEL OF AGGRESSIVE MEDULLOBLASTOMA REVEALS CKD INBHIBITION AS A POTENTIAL THERAPEUTIC MODALITY Neuro-Oncology. 17: iii25-iii26. DOI: 10.1093/Neuonc/Nov061.103 |
0.654 |
|
| 2014 |
Zhukova N, Ramaswamy V, Remke M, Martin DC, Castelo-Branco P, Zhang CH, Fraser M, Tse K, Poon R, Shih DJ, Baskin B, Ray PN, Bouffet E, Dirks P, von Bueren AO, ... ... Pomeroy SL, et al. WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma. Acta Neuropathologica Communications. 2: 174. PMID 25539912 DOI: 10.1186/S40478-014-0174-Y |
0.353 |
|
| 2014 |
Sengupta S, Weeraratne SD, Cho YJ, Pomeroy SL. Could α5-GABA-A receptor activation be used as a target for managing medulloblastomas? Cns Oncology. 3: 245-7. PMID 25286034 DOI: 10.2217/Cns.14.27 |
0.799 |
|
| 2014 |
He X, Zhang L, Chen Y, Remke M, Shih D, Lu F, Wang H, Deng Y, Yu Y, Xia Y, Wu X, Ramaswamy V, Hu T, Wang F, Zhou W, ... ... Pomeroy SL, et al. The G protein α subunit Gαs is a tumor suppressor in Sonic hedgehog-driven medulloblastoma. Nature Medicine. 20: 1035-42. PMID 25150496 DOI: 10.1038/Nm.3666 |
0.394 |
|
| 2014 |
Spence T, Sin-Chan P, Picard D, Barszczyk M, Hoss K, Lu M, Kim SK, Ra YS, Nakamura H, Fangusaro J, Hwang E, Kiehna E, Toledano H, Wang Y, Shi Q, ... ... Pomeroy SL, et al. CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity. Acta Neuropathologica. 128: 291-303. PMID 24839957 DOI: 10.1007/S00401-014-1291-1 |
0.429 |
|
| 2014 |
Kool M, Jones DT, Jäger N, Northcott PA, Pugh TJ, Hovestadt V, Piro RM, Esparza LA, Markant SL, Remke M, Milde T, Bourdeaut F, Ryzhova M, Sturm D, Pfaff E, ... ... Pomeroy SL, et al. Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. Cancer Cell. 25: 393-405. PMID 24651015 DOI: 10.1016/J.Ccr.2014.02.004 |
0.54 |
|
| 2014 |
Mack SC, Witt H, Piro RM, Gu L, Zuyderduyn S, Stütz AM, Wang X, Gallo M, Garzia L, Zayne K, Zhang X, Ramaswamy V, Jäger N, Jones DT, Sill M, ... ... Pomeroy SL, et al. Epigenomic alterations define lethal CIMP-positive ependymomas of infancy. Nature. 506: 445-50. PMID 24553142 DOI: 10.1038/Nature13108 |
0.347 |
|
| 2014 |
Shih DJ, Northcott PA, Remke M, Korshunov A, Ramaswamy V, Kool M, Luu B, Yao Y, Wang X, Dubuc AM, Garzia L, Peacock J, Mack SC, Wu X, Rolider A, ... ... Pomeroy SL, et al. Cytogenetic prognostication within medulloblastoma subgroups. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 886-96. PMID 24493713 DOI: 10.1200/Jco.2013.50.9539 |
0.307 |
|
| 2014 |
Archer TC, Pomeroy SL. A developmental program drives aggressive embryonal brain tumors. Nature Genetics. 46: 2-3. PMID 24370739 DOI: 10.1038/Ng.2857 |
0.643 |
|
| 2014 |
Gottardo NG, Hansford JR, McGlade JP, Alvaro F, Ashley DM, Bailey S, Baker DL, Bourdeaut F, Cho YJ, Clay M, Clifford SC, Cohn RJ, Cole CH, Dallas PB, Downie P, ... ... Pomeroy SL, et al. Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group. Acta Neuropathologica. 127: 189-201. PMID 24264598 DOI: 10.1007/S00401-013-1213-7 |
0.331 |
|
| 2014 |
Akhavanfard S, Vargas SO, Han M, Nitta M, Chang CB, Le LP, Fazlollahi L, Nguyen Q, Ma Y, Cosper A, Dias-Santagata D, Han JY, Bergethon K, Borger DR, Ellisen LW, ... Pomeroy SL, et al. Inactivation of the tumor suppressor WTX in a subset of pediatric tumors. Genes, Chromosomes & Cancer. 53: 67-77. PMID 24249259 DOI: 10.1002/Gcc.22118 |
0.431 |
|
| 2014 |
Sengupta S, Weeraratne SD, Sun H, Phallen J, Rallapalli SK, Teider N, Kosaras B, Amani V, Pierre-Francois J, Tang Y, Nguyen B, Yu F, Schubert S, Balansay B, Mathios D, ... ... Pomeroy SL, et al. α5-GABAA receptors negatively regulate MYC-amplified medulloblastoma growth. Acta Neuropathologica. 127: 593-603. PMID 24196163 DOI: 10.1007/S00401-013-1205-7 |
0.789 |
|
| 2014 |
Mora-Blanco EL, Mishina Y, Tillman EJ, Cho YJ, Thom CS, Pomeroy SL, Shao W, Roberts CW. Activation of β-catenin/TCF targets following loss of the tumor suppressor SNF5. Oncogene. 33: 933-8. PMID 23435428 DOI: 10.1038/Onc.2013.37 |
0.395 |
|
| 2014 |
Jonas O, Sengupta S, Calligaris D, Poe M, Methuku K, Francois JP, Cook J, Agar N, Pomeroy S, Langer R. ET-24 * A NOVEL TROJAN HORSE FOR IN-VIVO SENSITIVITY TESTING OF MEDULLOBLASTOMA THERAPIES Neuro-Oncology. 16: v84-v84. DOI: 10.1093/Neuonc/Nou255.24 |
0.674 |
|
| 2014 |
Eberhart C, Raabe E, Hanaford A, Pomeroy S. MODELLING HIGH MYC MEDULLOBLASTOMA AND OTHER BRAIN TUMORS USING HUMAN NEURAL STEM CELLS Neuro-Oncology. 16: iii4-iii4. DOI: 10.1093/Neuonc/Nou206.12 |
0.377 |
|
| 2013 |
Remke M, Ramaswamy V, Peacock J, Shih DJ, Koelsche C, Northcott PA, Hill N, Cavalli FM, Kool M, Wang X, Mack SC, Barszczyk M, Morrissy AS, Wu X, Agnihotri S, ... ... Pomeroy SL, et al. TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma. Acta Neuropathologica. 126: 917-29. PMID 24174164 DOI: 10.1007/S00401-013-1198-2 |
0.548 |
|
| 2013 |
Ramaswamy V, Remke M, Bouffet E, Faria CC, Perreault S, Cho YJ, Shih DJ, Luu B, Dubuc AM, Northcott PA, Schüller U, Gururangan S, McLendon R, Bigner D, Fouladi M, ... ... Pomeroy SL, et al. Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis. The Lancet. Oncology. 14: 1200-7. PMID 24140199 DOI: 10.1016/S1470-2045(13)70449-2 |
0.5 |
|
| 2013 |
Zhukova N, Ramaswamy V, Remke M, Pfaff E, Shih DJ, Martin DC, Castelo-Branco P, Baskin B, Ray PN, Bouffet E, von Bueren AO, Jones DT, Northcott PA, Kool M, Sturm D, ... ... Pomeroy SL, et al. Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 2927-35. PMID 23835706 DOI: 10.1200/Jco.2012.48.5052 |
0.389 |
|
| 2013 |
Jones DT, Hutter B, Jäger N, Korshunov A, Kool M, Warnatz HJ, Zichner T, Lambert SR, Ryzhova M, Quang DA, Fontebasso AM, Stütz AM, Hutter S, Zuckermann M, Sturm D, ... ... Pomeroy SL, et al. Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nature Genetics. 45: 927-32. PMID 23817572 DOI: 10.1038/Ng.2682 |
0.601 |
|
| 2013 |
Ramkissoon LA, Horowitz PM, Craig JM, Ramkissoon SH, Rich BE, Schumacher SE, McKenna A, Lawrence MS, Bergthold G, Brastianos PK, Tabak B, Ducar MD, Van Hummelen P, MacConaill LE, Pouissant-Young T, ... ... Pomeroy SL, et al. Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1. Proceedings of the National Academy of Sciences of the United States of America. 110: 8188-93. PMID 23633565 DOI: 10.1073/Pnas.1300252110 |
0.384 |
|
| 2013 |
Archer TC, Weeraratne SD, Francois JP, Pomeroy SL. Abstract 5241: Identifying signaling pathways associated with medulloblastoma subtypes from "omic" data. Cancer Research. 73: 5241-5241. DOI: 10.1158/1538-7445.Am2013-5241 |
0.422 |
|
| 2013 |
Kool M, Jones DT, Jaeger N, Northcott PA, Hovestadt V, Schueller U, Remke M, Cho Y, Pomeroy S, Taylor MD, Eils R, Korshunov A, Lichter P, Pfister SM. Abstract 4591: Whole genome sequencing of SHH medulloblastomas predicts molecular groups of responders and non-responders to SMO-inhibition . Cancer Research. 73: 4591-4591. DOI: 10.1158/1538-7445.Am2013-4591 |
0.534 |
|
| 2013 |
Ambady P, Holdhoff M, Ferrigno C, Grossman S, Anderson MD, Liu D, Conrad C, Penas-Prado M, Gilbert MR, Yung AWK, Groot Jd, Aoki T, Nishikawa R, Sugiyama K, Nonoguchi N, ... ... Pomeroy SL, et al. Neuro/Medical Oncology Neuro-Oncology. 15: 120-120. DOI: 10.1093/Neuonc/Not182 |
0.417 |
|
| 2012 |
Archer TC, Pomeroy SL. Medulloblastoma biology in the post-genomic era. Future Oncology (London, England). 8: 1597-604. PMID 23231521 DOI: 10.2217/Fon.12.151 |
0.66 |
|
| 2012 |
Northcott PA, Jones DT, Kool M, Robinson GW, Gilbertson RJ, Cho YJ, Pomeroy SL, Korshunov A, Lichter P, Taylor MD, Pfister SM. Medulloblastomics: the end of the beginning. Nature Reviews. Cancer. 12: 818-34. PMID 23175120 DOI: 10.1038/Nrc3410 |
0.352 |
|
| 2012 |
Jones DT, Jäger N, Kool M, Zichner T, Hutter B, Sultan M, Cho YJ, Pugh TJ, Hovestadt V, Stütz AM, Rausch T, Warnatz HJ, Ryzhova M, Bender S, Sturm D, ... ... Pomeroy SL, et al. Dissecting the genomic complexity underlying medulloblastoma. Nature. 488: 100-5. PMID 22832583 DOI: 10.1038/Nature11284 |
0.58 |
|
| 2012 |
Northcott PA, Shih DJ, Peacock J, Garzia L, Morrissy AS, Zichner T, Stütz AM, Korshunov A, Reimand J, Schumacher SE, Beroukhim R, Ellison DW, Marshall CR, Lionel AC, Mack S, ... ... Pomeroy SL, et al. Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature. 488: 49-56. PMID 22832581 DOI: 10.1038/Nature11327 |
0.354 |
|
| 2012 |
Pugh TJ, Weeraratne SD, Archer TC, Pomeranz Krummel DA, Auclair D, Bochicchio J, Carneiro MO, Carter SL, Cibulskis K, Erlich RL, Greulich H, Lawrence MS, Lennon NJ, McKenna A, Meldrim J, ... ... Pomeroy SL, et al. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature. 488: 106-10. PMID 22820256 DOI: 10.1038/Nature11329 |
0.775 |
|
| 2012 |
Picard D, Miller S, Hawkins CE, Bouffet E, Rogers HA, Chan TS, Kim SK, Ra YS, Fangusaro J, Korshunov A, Toledano H, Nakamura H, Hayden JT, Chan J, Lafay-Cousin L, ... ... Pomeroy SL, et al. Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis. The Lancet. Oncology. 13: 838-48. PMID 22691720 DOI: 10.1016/S1470-2045(12)70257-7 |
0.329 |
|
| 2012 |
McKenna ES, Tamayo P, Cho YJ, Tillman EJ, Mora-Blanco EL, Sansam CG, Koellhoffer EC, Pomeroy SL, Roberts CW. Epigenetic inactivation of the tumor suppressor BIN1 drives proliferation of SNF5-deficient tumors. Cell Cycle (Georgetown, Tex.). 11: 1956-65. PMID 22544318 DOI: 10.4161/Cc.20280 |
0.585 |
|
| 2012 |
Manley PE, McKendrick K, McGillicudy M, Chi SN, Kieran MW, Cohen LE, Kothare S, Michael Scott R, Goumnerova LC, Sun P, London W, Marcus KJ, Pomeroy SL, Ullrich NJ. Sleep dysfunction in long term survivors of craniopharyngioma. Journal of Neuro-Oncology. 108: 543-9. PMID 22528788 DOI: 10.1007/S11060-012-0859-7 |
0.53 |
|
| 2012 |
Archer TC, Weeraratne SD, Pomeroy SL. Hedgehog-GLI pathway in medulloblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 2154-6. PMID 22508821 DOI: 10.1200/Jco.2011.41.1181 |
0.793 |
|
| 2012 |
Weeraratne SD, Amani V, Teider N, Pierre-Francois J, Winter D, Kye MJ, Sengupta S, Archer T, Remke M, Bai AH, Warren P, Pfister SM, Steen JA, Pomeroy SL, Cho YJ. Pleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastoma. Acta Neuropathologica. 123: 539-52. PMID 22402744 DOI: 10.1007/S00401-012-0969-5 |
0.758 |
|
| 2012 |
Kool M, Korshunov A, Remke M, Jones DT, Schlanstein M, Northcott PA, Cho YJ, Koster J, Schouten-van Meeteren A, van Vuurden D, Clifford SC, Pietsch T, von Bueren AO, Rutkowski S, McCabe M, ... ... Pomeroy SL, et al. Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathologica. 123: 473-84. PMID 22358457 DOI: 10.1007/S00401-012-0958-8 |
0.363 |
|
| 2012 |
Bai AH, Milde T, Remke M, Rolli CG, Hielscher T, Cho YJ, Kool M, Northcott PA, Jugold M, Bazhin AV, Eichmüller SB, Kulozik AE, Pscherer A, Benner A, Taylor MD, ... Pomeroy SL, et al. MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma. Acta Neuropathologica. 123: 529-38. PMID 22134538 DOI: 10.1007/S00401-011-0924-X |
0.49 |
|
| 2012 |
Taylor MD, Northcott PA, Korshunov A, Remke M, Cho YJ, Clifford SC, Eberhart CG, Parsons DW, Rutkowski S, Gajjar A, Ellison DW, Lichter P, Gilbertson RJ, Pomeroy SL, Kool M, et al. Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathologica. 123: 465-72. PMID 22134537 DOI: 10.1007/S00401-011-0922-Z |
0.335 |
|
| 2012 |
Northcott PA, Shih DJ, Remke M, Cho YJ, Kool M, Hawkins C, Eberhart CG, Dubuc A, Guettouche T, Cardentey Y, Bouffet E, Pomeroy SL, Marra M, Malkin D, Rutka JT, et al. Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples. Acta Neuropathologica. 123: 615-26. PMID 22057785 DOI: 10.1007/S00401-011-0899-7 |
0.519 |
|
| 2012 |
Jäger N, Jones DT, Kool M, Zichner T, Hutter B, Sultan M, Cho Y, Pugh TJ, Hovestadt V, Stütz AM, Rausch T, Warnatz H, Brors B, Northcott PA, Taylor MD, ... ... Pomeroy SL, et al. ICGC PedBrain - dissecting the genomic complexity underlying medulloblastoma using whole-genome sequencing Bmc Proceedings. 6. DOI: 10.1186/1753-6561-6-S6-P43 |
0.447 |
|
| 2012 |
Jones DT, Jaeger N, Cho Y, Pugh TJ, Rausch T, Stuetz A, Zichner T, Weischenfeldt J, Zapatka M, Benes V, Blake J, Northcott PA, Remke M, Witt H, Witt O, ... ... Pomeroy SL, et al. Abstract 4872: ICGC PedBrain Tumor - Next-generation sequencing identifies novel subgroup-specific mutations and copy number aberrations in medulloblastoma Cancer Research. 72: 4872-4872. DOI: 10.1158/1538-7445.Am2012-4872 |
0.603 |
|
| 2012 |
Pugh TJ, Cho Y, Archer T, Weeraratne D, Jones DTW, Jaeger N, Auclair D, Cibulskis K, Lawrence MS, Ramos AH, Shefler E, Sivachenko A, Tamayo P, Mesirov JP, Gabriel SB, ... ... Pomeroy SL, et al. Abstract 4868: Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations within a wide spectrum of genetic heterogeneity Cancer Research. 72: 4868-4868. DOI: 10.1158/1538-7445.Am2012-4868 |
0.711 |
|
| 2012 |
Kool M, Jones DTW, Remke M, Jaeger N, Korshunov A, Schlanstein M, Northcott PA, Meeteren NSv, Vuurden Dv, Clifford SC, Pietsch T, Bueren AOV, Rutkowski S, Cho Y, McCabe M, ... ... Pomeroy S, et al. Abstract 2492: Integrated genomics on molecular subgroups in medulloblastoma Cancer Research. 72: 2492-2492. DOI: 10.1158/1538-7445.Am2012-2492 |
0.547 |
|
| 2012 |
Weeraratne SD, Archer T, Pugh TJ, Hargreaves D, Yu F, Kautzman A, Jones DTW, Jaeger N, Tamayo P, Mesirov JP, Pfister SM, Lichter P, Crabtree G, Meyerson M, Pomeroy SL, et al. Abstract 1313: Mutually exclusive somatic mutations in WNT pathway medulloblastomas reveal a critical interaction between DDX3X and SMARCA4 Cancer Research. 72: 1313-1313. DOI: 10.1158/1538-7445.Am2012-1313 |
0.684 |
|
| 2011 |
Ullrich NJ, Pomeroy SL. Neuro-oncology training for the child neurology resident. Seminars in Pediatric Neurology. 18: 120-2. PMID 22036496 DOI: 10.1016/J.Spen.2011.06.010 |
0.515 |
|
| 2011 |
Archer TC, Pomeroy SL. Posterior fossa ependymomas: a tale of two subtypes. Cancer Cell. 20: 133-4. PMID 21840477 DOI: 10.1016/J.Ccr.2011.08.003 |
0.642 |
|
| 2011 |
Winkfield KM, Tsai HK, Yao X, Larson E, Neuberg D, Pomeroy SL, Ullrich NJ, Cohen LE, Kieran MW, Scott RM, Goumnerova LC, Marcus KJ. Long-term clinical outcomes following treatment of childhood craniopharyngioma. Pediatric Blood & Cancer. 56: 1120-6. PMID 21488157 DOI: 10.1002/Pbc.22884 |
0.568 |
|
| 2011 |
Pomeroy SL, Cho YJ. Molecular fingerprints of medulloblastoma and their application to clinical practice. Future Oncology (London, England). 7: 327-9. PMID 21417897 DOI: 10.2217/Fon.11.15 |
0.451 |
|
| 2011 |
Tamayo P, Cho YJ, Tsherniak A, Greulich H, Ambrogio L, Schouten-van Meeteren N, Zhou T, Buxton A, Kool M, Meyerson M, Pomeroy SL, Mesirov JP. Predicting relapse in patients with medulloblastoma by integrating evidence from clinical and genomic features. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1415-23. PMID 21357789 DOI: 10.1200/Jco.2010.28.1675 |
0.511 |
|
| 2011 |
Wu H, Pomeroy SL, Ferreira M, Teider N, Mariani J, Nakayama KI, Hatakeyama S, Tron VA, Saltibus LF, Spyracopoulos L, Leng RP. UBE4B promotes Hdm2-mediated degradation of the tumor suppressor p53. Nature Medicine. 17: 347-55. PMID 21317885 DOI: 10.1038/Nm.2283 |
0.742 |
|
| 2011 |
Balaj L, Lessard R, Dai L, Cho YJ, Pomeroy SL, Breakefield XO, Skog J. Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nature Communications. 2: 180. PMID 21285958 DOI: 10.1038/Ncomms1180 |
0.481 |
|
| 2011 |
Weeraratne SD, Amani V, Neiss A, Teider N, Scott DK, Pomeroy SL, Cho YJ. miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma. Neuro-Oncology. 13: 165-75. PMID 21177782 DOI: 10.1093/Neuonc/Noq179 |
0.755 |
|
| 2011 |
Cho YJ, Tsherniak A, Tamayo P, Santagata S, Ligon A, Greulich H, Berhoukim R, Amani V, Goumnerova L, Eberhart CG, Lau CC, Olson JM, Gilbertson RJ, Gajjar A, Delattre O, ... ... Pomeroy SL, et al. Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1424-30. PMID 21098324 DOI: 10.1200/Jco.2010.28.5148 |
0.388 |
|
| 2011 |
McKenna ES, Tamayo P, Cho Y, Mora-Blanco EL, Sansam CG, Tillman EJ, Koellhoffer EC, Pomeroy SL, Roberts CWM. Abstract 66: Epigenetic inactivation of the tumor suppressor BIN1 drives proliferation of SNF5-deficient tumors Cancer Research. 71: 66-66. DOI: 10.1158/1538-7445.Am2011-66 |
0.598 |
|
| 2011 |
Cho Y, Tamayo P, Tsherniak A, Meyerson M, Mesirov JP, Pomeroy SL. Abstract 4760: Molecular classification and risk-stratification in medulloblastoma using an integrative genomic approach Cancer Research. 71: 4760-4760. DOI: 10.1158/1538-7445.Am2011-4760 |
0.559 |
|
| 2011 |
Akhavanfard S, Rivera MN, Dias-Santagata DC, Vargas SO, Pomeroy S, Haber DA, Iafrate AJ. Abstract 4349: The tumor suppressor WTX is inactivated in a subset of pediatric tumors Cancer Research. 71: 4349-4349. DOI: 10.1158/1538-7445.Am2011-4349 |
0.429 |
|
| 2011 |
Pavel H, Ajeawung N, Faure R, Poirier D, Kamnasaran D, Ajeawung N, Joshi H, Kamnasaran D, Poirier D, Ajeawung N, Kamnasaran D, Lun X, Zemp F, Sun B, Stechishin O, ... ... Pomeroy SL, et al. PRECLINICAL EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY Neuro-Oncology. 13: iii107-iii120. DOI: 10.1093/Neuonc/Nor158 |
0.768 |
|
| 2011 |
Kool M, Koster J, Remke M, Korshunov A, Hielscher T, Witt H, Northcott P, Schouten-van Meeteren A, Clifford S, Pietsch T, Buehren Av, Rutkowski S, Cho Y, Versteeg R, Haberler C, ... ... Pomeroy S, et al. Molecular subtypes in medulloblastoma: an International meta-analysis for profiles, genetic aberrations, clinicopathological features AND SURVIVAL Klinische PäDiatrie. 223. DOI: 10.1055/S-0031-1292590 |
0.486 |
|
| 2010 |
Jagani Z, Mora-Blanco EL, Sansam CG, McKenna ES, Wilson B, Chen D, Klekota J, Tamayo P, Nguyen PT, Tolstorukov M, Park PJ, Cho YJ, Hsiao K, Buonamici S, Pomeroy SL, et al. Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway. Nature Medicine. 16: 1429-33. PMID 21076395 DOI: 10.1038/Nm.2251 |
0.556 |
|
| 2010 |
Wilson BG, Wang X, Shen X, McKenna ES, Lemieux ME, Cho YJ, Koellhoffer EC, Pomeroy SL, Orkin SH, Roberts CW. Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation. Cancer Cell. 18: 316-28. PMID 20951942 DOI: 10.1016/J.Ccr.2010.09.006 |
0.552 |
|
| 2010 |
Teider N, Scott DK, Neiss A, Weeraratne SD, Amani VM, Wang Y, Marquez VE, Cho YJ, Pomeroy SL. Neuralized1 causes apoptosis and downregulates Notch target genes in medulloblastoma. Neuro-Oncology. 12: 1244-56. PMID 20847082 DOI: 10.1093/Neuonc/Noq091 |
0.802 |
|
| 2010 |
Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, Barretina J, Boehm JS, Dobson J, Urashima M, Mc Henry KT, Pinchback RM, Ligon AH, Cho YJ, Haery L, ... ... Pomeroy SL, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 463: 899-905. PMID 20164920 DOI: 10.1038/Nature08822 |
0.515 |
|
| 2010 |
Wilson BG, Wang X, Shen X, McKenna ES, Lemieux ME, Cho Y, Koelhoffer EC, Pomeroy SL, Orkin SH, Roberts CWM. Abstract LB-237: Epigenetic antagonism between Polycomb and SWI/SNF complexes duringoncogenic transformation Cancer Research. 71: 4799-4799. DOI: 10.1158/1538-7445.Am2011-Lb-237 |
0.564 |
|
| 2010 |
Li M, Lee K, Lu Y, Clarke I, Shih D, Meter TV, Zhou L, Picard D, Modena P, Pomeroy S, Lau CC, Taylor MD, Bouffet E, Rutka JT, Gajjar A, et al. Abstract 4355: The C19MC miRNA polycistron are frequent targets of gene amplification in aggressive primitive neuroectodermal brain tumors and encode oncogenic miRNAs that inhibit normal neural stem cell differentiation Cancer Research. 70: 4355-4355. DOI: 10.1158/1538-7445.Am10-4355 |
0.312 |
|
| 2010 |
Li M, Lee KF, Lu Y, Clarke I, Shih D, Eberhart C, Peter Collins V, Van Meter T, Picard D, Zhou L, Boutros P, Modena P, Liang ML, Scherer SW, Bouffet E, ... ... Pomeroy S, et al. Frequent Amplification of a chr19q13.41 MicroRNA Polycistron in Aggressive Primitive Neuroectodermal Brain Tumors (DOI:10.1016/j.ccr.2009.10.025) Cancer Cell. 17: 413. DOI: 10.1016/J.Ccr.2010.03.016 |
0.376 |
|
| 2009 |
Li M, Lee KF, Lu Y, Clarke I, Shih D, Eberhart C, Collins VP, Van Meter T, Picard D, Zhou L, Boutros PC, Modena P, Liang ML, Scherer SW, Bouffet E, ... ... Pomeroy SL, et al. Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors. Cancer Cell. 16: 533-46. PMID 19962671 DOI: 10.1016/J.Ccr.2009.10.025 |
0.374 |
|
| 2009 |
Pomeroy SL. Pathologic intracellular signaling in childhood pilocytic astrocytomas. Neurology. 73: 1522-3. PMID 19812379 DOI: 10.1212/Wnl.0B013E3181C1850E |
0.403 |
|
| 2008 |
McKenna ES, Sansam CG, Cho YJ, Greulich H, Evans JA, Thom CS, Moreau LA, Biegel JA, Pomeroy SL, Roberts CW. Loss of the epigenetic tumor suppressor SNF5 leads to cancer without genomic instability. Molecular and Cellular Biology. 28: 6223-33. PMID 18710953 DOI: 10.1128/Mcb.00658-08 |
0.552 |
|
| 2008 |
Schlisio S, Kenchappa RS, Vredeveld LC, George RE, Stewart R, Greulich H, Shahriari K, Nguyen NV, Pigny P, Dahia PL, Pomeroy SL, Maris JM, Look AT, Meyerson M, Peeper DS, et al. The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor. Genes & Development. 22: 884-93. PMID 18334619 DOI: 10.1101/Gad.1648608 |
0.382 |
|
| 2008 |
Goumnerova L, Drzymalski D, Kieran M, Pomeroy S, Scott RM, Tarbell N. Long-Term Neurological and Neurosurgical Outcomes After Surgery Only in Children with Low-Grade Brain Tumors Journal of Neurosurgery. 1. DOI: 10.3171/Ped/2008/1/4/Paper16 |
0.372 |
|
| 2008 |
Ullrich NJ, Pomeroy SL. Neurologic complications of pediatric systemic cancer Cancer Neurology in Clinical Practice: Neurologic Complications of Cancer and Its Treatment: Second Edition. 607-619. DOI: 10.1007/978-1-59745-412-4_32 |
0.488 |
|
| 2007 |
Lo KC, Ma C, Bundy BN, Pomeroy SL, Eberhart CG, Cowell JK. Gain of 1q is a potential univariate negative prognostic marker for survival in medulloblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 7022-8. PMID 18056178 DOI: 10.1158/1078-0432.Ccr-07-1420 |
0.37 |
|
| 2007 |
Ullrich NJ, Robertson R, Kinnamon DD, Scott RM, Kieran MW, Turner CD, Chi SN, Goumnerova L, Proctor M, Tarbell NJ, Marcus KJ, Pomeroy SL. Moyamoya following cranial irradiation for primary brain tumors in children. Neurology. 68: 932-8. PMID 17372129 DOI: 10.1212/01.Wnl.0000257095.33125.48 |
0.606 |
|
| 2007 |
Lo KC, Rossi MR, Burkhardt T, Pomeroy SL, Cowell JK. Overlay analysis of the oligonucleotide array gene expression profiles and copy number abnormalities as determined by array comparative genomic hybridization in medulloblastomas. Genes, Chromosomes & Cancer. 46: 53-66. PMID 17044047 DOI: 10.1002/Gcc.20388 |
0.323 |
|
| 2007 |
Ferreira M, Pomeroy SL. Expression Profiling of Embryonal Tumors Reveals the mTOR Pathway as a Therapeutic Target Neurosurgery. 61: 210-211. DOI: 10.1227/01.Neu.0000279928.72999.C7 |
0.393 |
|
| 2006 |
Ullrich NJ, Pomeroy SL. Molecular genetics of pediatric central nervous system tumors. Current Oncology Reports. 8: 423-9. PMID 17040620 DOI: 10.1007/S11912-006-0070-0 |
0.64 |
|
| 2006 |
De Bortoli M, Castellino RC, Lu XY, Deyo J, Sturla LM, Adesina AM, Perlaky L, Pomeroy SL, Lau CC, Man TK, Rao PH, Kim JY. Medulloblastoma outcome is adversely associated with overexpression of EEF1D, RPL30, and RPS20 on the long arm of chromosome 8. Bmc Cancer. 6: 223. PMID 16968546 DOI: 10.1186/1471-2407-6-223 |
0.734 |
|
| 2006 |
Ullrich NJ, Marcus K, Pomeroy SL, Turner CD, Zimmerman M, Lehmann LE, Scott RM, Goumnerova L, Gillan E, Kieran MW, Chi SN. Transverse myelitis after therapy for primitive neuroectodermal tumors. Pediatric Neurology. 35: 122-5. PMID 16876009 DOI: 10.1016/J.Pediatrneurol.2006.01.013 |
0.586 |
|
| 2006 |
Ullrich NJ, Pomeroy SL. Microarray analysis and proteomic approaches to drug development Handbook of Brain Tumor Chemotherapy. 74-88. DOI: 10.1016/B978-012088410-0/50043-3 |
0.482 |
|
| 2005 |
Isakoff MS, Sansam CG, Tamayo P, Subramanian A, Evans JA, Fillmore CM, Wang X, Biegel JA, Pomeroy SL, Mesirov JP, Roberts CW. Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation. Proceedings of the National Academy of Sciences of the United States of America. 102: 17745-50. PMID 16301525 DOI: 10.1073/Pnas.0509014102 |
0.439 |
|
| 2005 |
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America. 102: 15545-50. PMID 16199517 DOI: 10.1073/Pnas.0506580102 |
0.314 |
|
| 2005 |
Sturla LM, Cowan CW, Guenther L, Castellino RC, Kim JY, Pomeroy SL. A novel role for extracellular signal-regulated kinase 5 and myocyte enhancer factor 2 in medulloblastoma cell death. Cancer Research. 65: 5683-9. PMID 15994942 DOI: 10.1158/0008-5472.Can-04-2283 |
0.714 |
|
| 2005 |
Fleischman A, Brue C, Poussaint TY, Kieran M, Pomeroy SL, Goumnerova L, Scott RM, Cohen LE. Diencephalic syndrome: a cause of failure to thrive and a model of partial growth hormone resistance. Pediatrics. 115: e742-8. PMID 15930202 DOI: 10.1542/Peds.2004-2237 |
0.314 |
|
| 2005 |
Judkins AR, Burger PC, Hamilton RL, Kleinschmidt-DeMasters B, Perry A, Pomeroy SL, Rosenblum MK, Yachnis AT, Zhou H, Rorke LB, Biegel JA. INI1 protein expression distinguishes atypical teratoid/rhabdoid tumor from choroid plexus carcinoma. Journal of Neuropathology and Experimental Neurology. 64: 391-7. PMID 15892296 DOI: 10.1093/Jnen/64.5.391 |
0.424 |
|
| 2005 |
Zimmerman MA, Goumnerova LC, Proctor M, Scott RM, Marcus K, Pomeroy SL, Turner CD, Chi SN, Chordas C, Kieran MW. Continuous remission of newly diagnosed and relapsed central nervous system atypical teratoid/rhabdoid tumor. Journal of Neuro-Oncology. 72: 77-84. PMID 15803379 DOI: 10.1007/S11060-004-3115-Y |
0.322 |
|
| 2005 |
Marcus KJ, Goumnerova L, Billett AL, Lavally B, Scott RM, Bishop K, Xu R, Young Poussaint T, Kieran M, Kooy H, Pomeroy SL, Tarbell NJ. Stereotactic radiotherapy for localized low-grade gliomas in children: final results of a prospective trial. International Journal of Radiation Oncology, Biology, Physics. 61: 374-9. PMID 15667955 DOI: 10.1016/J.Ijrobp.2004.06.012 |
0.372 |
|
| 2005 |
Ullrich NJ, Scott RM, Pomeroy SL. Craniopharyngioma therapy: long-term effects on hypothalamic function. The Neurologist. 11: 55-60. PMID 15631644 DOI: 10.1097/01.Nrl.0000149971.27684.D4 |
0.584 |
|
| 2004 |
Pomeroy SL. Neural development and the ontogeny of central nervous system tumors. Neuron Glia Biology. 1: 127-33. PMID 16520827 DOI: 10.1017/S1740925X04000286 |
0.381 |
|
| 2004 |
Kho AT, Zhao Q, Cai Z, Butte AJ, Kim JY, Pomeroy SL, Rowitch DH, Kohane IS. Conserved mechanisms across development and tumorigenesis revealed by a mouse development perspective of human cancers. Genes & Development. 18: 629-40. PMID 15075291 DOI: 10.1101/Gad.1182504 |
0.614 |
|
| 2004 |
Fernandez-Teijeiro A, Betensky RA, Sturla LM, Kim JY, Tamayo P, Pomeroy SL. Combining gene expression profiles and clinical parameters for risk stratification in medulloblastomas. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 994-8. PMID 14970184 DOI: 10.1200/Jco.2004.03.036 |
0.725 |
|
| 2003 |
Ullrich NJ, Pomeroy SL. Pediatric brain tumors. Neurologic Clinics. 21: 897-913. PMID 14743655 DOI: 10.1016/S0733-8619(03)00014-8 |
0.636 |
|
| 2003 |
Pomeroy SL, Sturla LM. Molecular biology of medulloblastoma therapy. Pediatric Neurosurgery. 39: 299-304. PMID 14734863 DOI: 10.1159/000075257 |
0.687 |
|
| 2003 |
Kim JY, Nelson AL, Algon SA, Graves O, Sturla LM, Goumnerova LC, Rowitch DH, Segal RA, Pomeroy SL. Medulloblastoma tumorigenesis diverges from cerebellar granule cell differentiation in patched heterozygous mice. Developmental Biology. 263: 50-66. PMID 14568546 DOI: 10.1016/S0012-1606(03)00434-2 |
0.749 |
|
| 2003 |
McLaughlin ME, Robson CD, Kieran MW, Jacks T, Pomeroy SL, Cameron S. Marked regression of metastatic pilocytic astrocytoma during treatment with imatinib mesylate (STI-571, Gleevec): a case report and laboratory investigation. Journal of Pediatric Hematology/Oncology. 25: 644-8. PMID 12902920 DOI: 10.1097/00043426-200308000-00012 |
0.427 |
|
| 2003 |
Nelson AL, Algon SA, Munasinghe J, Graves O, Goumnerova L, Burstein D, Pomeroy SL, Kim JY. Magnetic resonance imaging of patched heterozygous and xenografted mouse brain tumors. Journal of Neuro-Oncology. 62: 259-67. PMID 12777077 DOI: 10.1023/A:1023339902812 |
0.573 |
|
| 2003 |
Carpentieri SC, Waber DP, Pomeroy SL, Scott RM, Goumnerova LC, Kieran MW, Billett AL, Tarbell NJ. Neuropsychological functioning after surgery in children treated for brain tumor. Neurosurgery. 52: 1348-56; discussion . PMID 12762880 DOI: 10.1227/01.Neu.0000064804.00766.62 |
0.32 |
|
| 2003 |
Sturla LM, Fernandez-Teijeiro A, Pomeroy SL. Application of microarrays to neurological disease. Archives of Neurology. 60: 676-82. PMID 12756130 DOI: 10.1001/Archneur.60.5.676 |
0.663 |
|
| 2003 |
Pomeroy SL, Ullrich NJ. Development of the Nervous System Fetal and Neonatal Physiology: Third Edition. 2: 1675-1698. DOI: 10.1016/B978-0-7216-9654-6.50168-5 |
0.49 |
|
| 2002 |
Kim JY, Koralnik IJ, LeFave M, Segal RA, Pfister LA, Pomeroy SL. Medulloblastomas and primitive neuroectodermal tumors rarely contain polyomavirus DNA sequences. Neuro-Oncology. 4: 165-70. PMID 12084346 DOI: 10.1093/Neuonc/4.3.165 |
0.556 |
|
| 2002 |
Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME, Kim JY, Goumnerova LC, Black PM, Lau C, Allen JC, Zagzag D, Olson JM, Curran T, Wetmore C, et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature. 415: 436-42. PMID 11807556 DOI: 10.1038/415436A |
0.736 |
|
| 2001 |
Dodge PR, Scaer M, Holmes SJ, Pomeroy SL, Feigin RD. Psychometric testing in bacterial meningitis: results of a long-term prospective study of infants and children treated between 1973 and 1977. Journal of Child Neurology. 16: 854-7. PMID 11732773 DOI: 10.1177/08830738010160111301 |
0.566 |
|
| 2001 |
Medina LS, Kuntz KM, Pomeroy S. Children with headache suspected of having a brain tumor: A cost-effectiveness analysis of diagnostic strategies Pediatrics. 108: 255-263. PMID 11483785 DOI: 10.1542/Peds.108.2.255 |
0.33 |
|
| 2001 |
Aguiar RC, Cox G, Pomeroy SL, Dahia PL. Analysis of the SDHD gene, the susceptibility gene for familial paraganglioma syndrome (PGL1), in pheochromocytomas. The Journal of Clinical Endocrinology and Metabolism. 86: 2890-4. PMID 11397905 DOI: 10.1210/Jcem.86.6.7547 |
0.334 |
|
| 2000 |
Siffert J, Poussaint TY, Goumnerova LC, Scott RM, LaValley B, Tarbell NJ, Pomeroy SL. Neurological dysfunction associated with postoperative cerebellar mutism. Journal of Neuro-Oncology. 48: 75-81. PMID 11026700 DOI: 10.1023/A:1006483531811 |
0.676 |
|
| 2000 |
Uemura Y, Pak SC, Luke C, Cataltepe S, Tsu C, Schick C, Kamachi Y, Pomeroy SL, Perlmutter DH, Silverman GA. Circulating serpin tumor markers SCCA1 and SCCA2 are not actively secreted but reside in the cytosol of squamous carcinoma cells. International Journal of Cancer. Journal International Du Cancer. 89: 368-77. PMID 10956412 DOI: 10.1002/1097-0215(20000720)89:4<368::Aid-Ijc9>3.0.Co;2-6 |
0.302 |
|
| 2000 |
Dong J, Gailani MR, Pomeroy SL, Reardon D, Bale AE. Identification of PATCHED mutations in medulloblastomas by direct sequencing. Human Mutation. 16: 89-90. PMID 10874314 DOI: 10.1002/1098-1004(200007)16:1<89::Aid-Humu18>3.0.Co;2-7 |
0.354 |
|
| 1999 |
Kim JY, Sutton ME, Lu DJ, Cho TA, Goumnerova LC, Goritchenko L, Kaufman JR, Lam KK, Billet AL, Tarbell NJ, Wu J, Allen JC, Stiles CD, Segal RA, Pomeroy SL. Activation of neurotrophin-3 receptor TrkC induces apoptosis in medulloblastomas. Cancer Research. 59: 711-9. PMID 9973222 |
0.635 |
|
| 1999 |
Dutton SC, Kieran M, Billett AL, Barnes P, Block P, Goumnerova L, Scott RM, LaVally B, Pomeroy S, Tarbell NJ. #313 Fractionated stereotactic radiotherapy for localized pediatric brain tumors: preliminary results of a prospective study Journal of Pediatric Hematology Oncology. 21: 318. DOI: 10.1097/00043426-199907000-00054 |
0.366 |
|
| 1999 |
Dutton SC, Goumnerova L, Billett AL, Kieran M, Barnes P, Scott RM, Vally BL, Pomeroy S, Tarbell NJ. 167 Fractionated stereotactic radiotherapy for localized pediatric brain tumors: Results of a prospective study International Journal of Radiation Oncology Biology Physics. 45: 234. DOI: 10.1016/S0360-3016(99)90185-2 |
0.365 |
|
| 1997 |
Pomeroy SL, Sutton ME, Goumnerova LC, Segal RA. Neurotrophins in cerebellar granule cell development and medulloblastoma. Journal of Neuro-Oncology. 35: 347-52. PMID 9440031 DOI: 10.1023/A:1005841206252 |
0.66 |
|
| 1997 |
Schwartz PM, Borghesani PR, Levy RL, Pomeroy SL, Segal RA. Abnormal cerebellar development and foliation in BDNF-/- mice reveals a role for neurotrophins in CNS patterning. Neuron. 19: 269-81. PMID 9292718 DOI: 10.1016/S0896-6273(00)80938-1 |
0.31 |
|
| 1995 |
Chapman CA, Waber DP, Bernstein JH, Pomeroy SL, LaVally B, Sallan SE, Tarbell N. Neurobehavioral and neurologic outcome in long-term survivors of posterior fossa brain tumors: role of age and perioperative factors. Journal of Child Neurology. 10: 209-12. PMID 7642890 DOI: 10.1177/088307389501000308 |
0.373 |
|
| 1994 |
Dunbar SF, Tarbell NJ, Kooy HM, Alexander E, Black PM, Barnes PD, Goumnerova L, Scott RM, Pomeroy SL, La Vally B. Stereotactic radiotherapy for pediatric and adult brain tumors: preliminary report. International Journal of Radiation Oncology, Biology, Physics. 30: 531-9. PMID 7928483 DOI: 10.1016/0360-3016(92)90938-E |
0.306 |
|
| 1994 |
Pomeroy SL. The p53 tumor suppressor gene and pediatric brain tumors. Current Opinion in Pediatrics. 6: 632-5. PMID 7849806 DOI: 10.1097/00008480-199412000-00003 |
0.421 |
|
| 1994 |
Tarbell NJ, Barnes P, Scott RM, Goumnerova L, Pomeroy SL, Black PM, Sallan SE, Billett A, LaVally B, Helmus A. Advances in radiation therapy for craniopharyngiomas. Pediatric Neurosurgery. 21: 101-7. PMID 7841067 DOI: 10.1159/000120870 |
0.317 |
|
| 1994 |
Segal RA, Goumnerova LC, Kwon YK, Stiles CD, Pomeroy SL. Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma. Proceedings of the National Academy of Sciences of the United States of America. 91: 12867-71. PMID 7809137 DOI: 10.1073/Pnas.91.26.12867 |
0.38 |
|
| 1992 |
LaMantia AS, Pomeroy SL, Purves D. Vital imaging of glomeruli in the mouse olfactory bulb. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 12: 976-88. PMID 1545246 DOI: 10.1523/Jneurosci.12-03-00976.1992 |
0.672 |
|
| 1992 |
Pomeroy SL. Brain tumors in children Current Opinion in Pediatrics. 4: 930-934. DOI: 10.1097/00008480-199212000-00004 |
0.354 |
|
| 1990 |
Pomeroy SL, LaMantia AS, Purves D. Postnatal construction of neural circuitry in the mouse olfactory bulb. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 10: 1952-66. PMID 2355260 DOI: 10.1523/Jneurosci.10-06-01952.1990 |
0.675 |
|
| 1990 |
Pomeroy SL, Holmes SJ, Dodge PR, Feigin RD. Seizures and other neurologic sequelae of bacterial meningitis in children. The New England Journal of Medicine. 323: 1651-7. PMID 2233962 DOI: 10.1056/Nejm199012133232402 |
0.57 |
|
| 1988 |
Pomeroy SL, Purves D. Neuron/glia relationships observed over intervals of several months in living mice. The Journal of Cell Biology. 107: 1167-75. PMID 3417780 DOI: 10.1083/Jcb.107.3.1167 |
0.476 |
|
| Show low-probability matches. |